Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeted photodynamic elimination of HER2 + breast cancer cells mediated by antibody–photosensitizer fusion proteins

Photochemical & Photobiological Sciences(2025)10.1007/s43630-025-00689-9Source: DataRank Database

Targeted photodynamic elimination of HER2 + breast cancer cells mediated by antibody–photosensitizer fusion proteins is a research paper published in Photochemical & Photobiological Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.42)OA: closedTopics (46)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Jian Hou,Jun Wan ORCID,Qinglian Liu ORCID,L. Zhou ORCID,Yi Li ORCID

Live enrichment

PubMed:40057920 OpenAlex:https://openalex.org/W4408258784

National Natural Science Foundation of China

Grant: 32171150

NIH

Grant: R01GM098592

National Institutes of Health

Grant: 5R01GM098592-08

Structural and Functional Studies of Hsp70 Molecular Chaperones

FWCI

1.42

Citation Percentile

0.8%

Citation Trend

2025

closedLicense: Springer Nature TDM

publisherhttps://link.springer.com/content/pdf/10.1007/s43630-025-00689-9.pdf

publisherhttps://link.springer.com/article/10.1007/s43630-025-00689-9/fulltext.html

journalhttps://doi.org/10.1007/s43630-025-00689-9

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40057920

Fields of Study

Photodynamic Therapy Research StudiesMonoclonal and Polyclonal Antibodies Researchbioluminescence and chemiluminescence research03 medical and health sciences0302 clinical medicine

MeSH Terms

TrastuzumabSARS-CoV-2Breast NeoplasmsCell SurvivalFemaleHumansPhotochemotherapyRecombinant Fusion ProteinsPhotosensitizing AgentsErb-b2 Receptor Tyrosine KinasesReceptor, ErbB-2Singlet OxygenCell Line, Tumor

Keywords

PhotosensitizerPhotodynamic therapyFusion proteinBreast cancerAntibodyCancer researchChemistryMedicineCancerInternal medicineImmunologyBiochemistryRecombinant DNAPhotochemistryGeneSinglet oxygenTrastuzumabSopp3Photosensitizing AgentsSARS-CoV-2Cell SurvivalRecombinant Fusion ProteinsBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesPhotochemotherapyCell Line, TumorHumansFemale